SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-680042
Filing Date
2016-08-12
Accepted
2016-08-12 08:11:56
Documents
69
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d211173d10q.htm 10-Q 674368
2 EX-10.1 d211173dex101.htm EX-10.1 78508
3 EX-31.1 d211173dex311.htm EX-31.1 5604
4 EX-31.2 d211173dex312.htm EX-31.2 5590
5 EX-32.1 d211173dex321.htm EX-32.1 3640
6 EX-32.2 d211173dex322.htm EX-32.2 3627
  Complete submission text file 0001193125-16-680042.txt   4072193

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dnai-20160630.xml EX-101.INS 635898
8 XBRL TAXONOMY EXTENSION SCHEMA dnai-20160630.xsd EX-101.SCH 51161
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dnai-20160630_cal.xml EX-101.CAL 54279
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dnai-20160630_def.xml EX-101.DEF 185058
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dnai-20160630_lab.xml EX-101.LAB 430037
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dnai-20160630_pre.xml EX-101.PRE 304209
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
ProNAi Therapeutics Inc (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 161826279
SIC: 2834 Pharmaceutical Preparations